HomeCompareMLHR vs JNJ

MLHR vs JNJ: Dividend Comparison 2026

MLHR yields 28.99% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLHR wins by $43.7K in total portfolio value
10 years
MLHR
MLHR
● Live price
28.99%
Share price
$38.66
Annual div
$11.21
5Y div CAGR
-7.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$74.0K
Annual income
$4,780.60
Full MLHR calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — MLHR vs JNJ

📍 MLHR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLHRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLHR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLHR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLHR
Annual income on $10K today (after 15% tax)
$2,463.80/yr
After 10yr DRIP, annual income (after tax)
$4,063.51/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, MLHR beats the other by $77.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLHR + JNJ for your $10,000?

MLHR: 50%JNJ: 50%
100% JNJ50/50100% MLHR
Portfolio after 10yr
$52.1K
Annual income
$4,735.00/yr
Blended yield
9.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MLHR
Analyst Ratings
3
Buy
4
Hold
Consensus: Hold
Altman Z
2.5
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLHR buys
0
JNJ buys
0
No recent congressional trades found for MLHR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLHRJNJ
Forward yield28.99%2.13%
Annual dividend / share$11.21$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-7.3%28%
Portfolio after 10y$74.0K$30.3K
Annual income after 10y$4,780.60$4,689.40
Total dividends collected$40.7K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: MLHR vs JNJ ($10,000, DRIP)

YearMLHR PortfolioMLHR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,387$2,686.99$10,592$272.30+$2.8KMLHR
2$17,440$3,116.35$11,289$357.73+$6.2KMLHR
3$22,179$3,517.35$12,123$472.89+$10.1KMLHR
4$27,606$3,875.15$13,141$629.86+$14.5KMLHR
5$33,718$4,178.86$14,408$846.81+$19.3KMLHR
6$40,500$4,421.83$16,021$1,151.60+$24.5KMLHR
7$47,936$4,601.44$18,122$1,588.22+$29.8KMLHR
8$56,010$4,718.46$20,930$2,228.20+$35.1KMLHR
9$64,707$4,776.39$24,792$3,191.91+$39.9KMLHR
10$74,017$4,780.60$30,274$4,689.40+$43.7KMLHR

MLHR vs JNJ: Complete Analysis 2026

MLHRStock

Herman Miller, Inc. engages in the research, design, manufacture, and distribution of office furniture systems, seating products, other freestanding furniture elements, textiles, home furnishings, and related services worldwide. The company offers seating products under the Embody, Aeron, Mirra2, Setu, Sayl, Verus, Cosm, Lino, Verus, Celle, Equa, Taper, and Ergon names; and modular systems under the Canvas Office Landscape, Locale, Public Office Landscape, Layout Studio, Action Office, Ethospace, Arras, Prospect, Overlay, and Resolve names. It also provides storage products under the Meridian and Tu names; wood case goods under the Geiger name; freestanding furniture products under the Abak, Intent, Sense, and Envelop names; healthcare products under the Palisade, Compass, Nala, Ava, and Nemschoff names; Thrive portfolio of ergonomic solutions, ergonomic, and technology support products under the Colebrook Bosson Saunders name; and textiles under the Maharam name, as well as Live Platform system of cloud-connected furnishings, applications, and dashboards. In addition, the company offers products for residential settings under the Eames, Eames Soft Pad, HAY, Nelson, Bubble Lamps, Airia, Ardea, Bumper, Burdick Group, Everywhere, Claw, Caper, Distil, Envelope, Formwork, Full Round, H Frame, I Beam, Landmark, Logic Mini, Logic Power Access Solutions, Renew, Rolled Arm, Scissor, Sled, Soft Pad, Swoop, Tone, Twist, Ward Bennett, and Wireframe names. Its products are used in offices and related conference, lobby, and lounge areas; transportation terminals; hospitals, clinics, and other healthcare facilities; industrial and educational settings; and residential and other environments. The company markets its products through its sales staff, own dealer network, independent dealers and retailers, and independent contract office furniture dealers, as well as through e-commerce Website. Herman Miller, Inc. was founded in 1905 and is headquartered in Zeeland, Michigan.

Full MLHR Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MLHR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLHR vs SCHDMLHR vs JEPIMLHR vs OMLHR vs KOMLHR vs MAINMLHR vs ABBVMLHR vs MRKMLHR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.